Europe

Portugal’s Infarmed Faces EU Law Clash Over CBD-Infused Cosmetics via GCI

 

THE WHAT?

Portugal’s National Authority for Medicines and Health Products (Infarmed) has ordered the removal of multiple CBD-based cosmetic products from the market. The agency’s decision hinges on the claim that CBD from cannabis extracts is classified as a narcotic in Portugal, conflicting with the European Union’s principle of free movement of goods.

 

THE DETAILS 

  • Infarmed mandated the withdrawal of CBD-infused products from brands including SVR, Naturasor, and Dermacol.
  • The regulator’s position directly contradicts the European Court of Justice’s 2020 ruling that CBD is not a narcotic under international conventions.
  • By blocking these products, Portugal risks violating EU law, which forbids member states from restricting legally produced CBD merchandise without scientific evidence of harm.
  • The enforcement disrupts the growing local market for CBD skin care and may push manufacturers toward reformulation or synthetic alternatives to circumvent regulations.

 

Read more…

Recent Posts

Final program Cosmetotest on May 14-15, 2025, Preclinical and clinical testing Symposium in Lyon & Hybrid

LIVE & HYBRID All you need to know about preclinical and clinical testing is at…

Save the Date: April 28th, Testing Trends Webinar – Feedback on the Testing and Lab Zone x in-cosmetics global

👉 Register: Exclusive webinar in English April 28th 2025 at 3:00 PM [CEST]   We…

Save the Date: May 8th – What’s trending in cosmetics, A.I and other things! Webinar via Personal Care Insights

HOW AI IS SHAPING BIO-BASED BEAUTY AND PERSONALIZED PRODUCTS 📆 May, 8th 2025 ⏱️ 16:00…